We are live on
!
Find out more
Group One Trading Portfolio holdings
AUM
$52.2B
1-Year Est. Return
104.56%
This Fund
S&P 500
This Quarter
Est. Return
+9.94%
1 Year Est. Return
+104.56%
3 Year Est. Return
+314.05%
5 Year Est. Return
+338.55%
10 Year Est. Return
+1,999.92%
AUM
$43B
AUM Growth
-$7.89B
(-16%)
Cap. Flow
-$3.97B
Cap. Flow
% of AUM
-9.24%
Top 10 Holdings %
Top 10 Hldgs %
21.79%
Holding
8,577
New
1,058
Increased
2,469
Reduced
3,270
Closed
1,444
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$158M |
| 2 |
Microsoft
MSFT
|
+$62.9M |
| 3 |
Meta Platforms (Facebook)
META
|
+$55.8M |
| 4 |
Boeing
BA
|
+$34.1M |
| 5 |
ARK Innovation ETF
ARKK
|
+$29.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$128M |
| 2 |
NVIDIA
NVDA
|
+$89M |
| 3 |
Apple
AAPL
|
+$86.7M |
| 4 |
Advanced Micro Devices
AMD
|
+$47.6M |
| 5 |
Biogen
BIIB
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.37% |
| 2 | Healthcare | 1.33% |
| 3 | Consumer Discretionary | 0.84% |
| 4 | Energy | 0.65% |
| 5 | Financials | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HYFT
6126
PUT
MindWalk Holdings
HYFT
$61.6M
| $7.95K | ﹤0.01% |
1,500
-5,900
| -80% | -$29.9K |
|
6127
Getty Images
GETY
$183M
| $7.93K | ﹤0.01% |
1,429
-10,034
| -88% | -$56.1K |
|
|
MTLS
6128
PUT
Materialise
MTLS
$396M
| $7.92K | ﹤0.01% |
900
-10,200
| -92% | -$101K |
|
6129
Forte Biosciences
FBRX
$1.57B
| $7.89K | ﹤0.01% |
316
-446
| -59% | -$11.4K |
|
|
VIRX
6130
CALL
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $7.88K | ﹤0.01% |
5,400
| – | – |
|
|
SRTA
6131
PUT
Strata Critical Medical Inc
SRTA
$512M
| $7.88K | ﹤0.01% |
2,200
-5,300
| -71% | -$22.6K |
|
|
ABST
6132
DELISTED
Absolute Software Corp
ABST
| $7.85K | ﹤0.01% |
+752
| New | +$7.85K |
|
|
QCLS
6133
Q/C Technologies Inc
QCLS
$22.9M
| $7.77K | ﹤0.01% |
2
+1
| +100% | +$6.29K |
|
|
AKLI
6134
DELISTED
Akili Inc
AKLI
| $7.77K | ﹤0.01% |
6,940
-4,306
| -38% | -$7.58K |
|
|
LCI
6135
CALL
DELISTED
Lannett Company, Inc.
LCI
| $7.76K | ﹤0.01% |
+3,725
| New | +$8.02K |
|
6136
PUT
AC Immune
ACIU
$240M
| $7.75K | ﹤0.01% |
3,800
-2,000
| -34% | -$5.16K |
|
6137
CALL
NatWest
NWG
$76.4B
| $7.75K | ﹤0.01% |
1,200
-800
| -40% | -$4.69K |
|
6138
Phillips Edison & Co
PECO
$5.24B
| $7.74K | ﹤0.01% |
243
-27,388
| -99% | -$842K |
|
6139
CALL
Pacira BioSciences
PCRX
$997M
| $7.72K | ﹤0.01% |
200
-6,000
| -97% | -$292K |
|
6140
CALL
OraSure Technologies
OSUR
$279M
| $7.71K | ﹤0.01% |
1,600
-7,100
| -82% | -$32.5K |
|
|
DADA
6141
DELISTED
Dada Nexus
DADA
| $7.71K | ﹤0.01% |
+1,106
| New | +$5.79K |
|
6142
Xperi
XPER
$348M
| $7.7K | ﹤0.01% |
+894
| New | +$10.2K |
|
6143
PUT
CBRE Group
CBRE
$42.9B
| $7.7K | ﹤0.01% |
+100
| New | +$7.38K |
|
|
DX
6144
CALL
Dynex Capital
DX
$3.21B
| $7.63K | ﹤0.01% |
600
-1,200
| -67% | -$14.9K |
|
6145
CALL
1stdibs.com
DIBS
$171M
| $7.62K | ﹤0.01% |
1,500
-205,000
| -99% | -$1.24M |
|
6146
AYTU BioPharma
AYTU
$25.3M
| $7.6K | ﹤0.01% |
2,010
-20
| -1% | -$75 |
|
|
CBAY
6147
PUT
DELISTED
Cymabay Therapeutics
CBAY
| $7.52K | ﹤0.01% |
1,200
| – | – |
|
6148
Alzamend Neuro
ALZN
$6.56M
| $7.49K | ﹤0.01% |
10
-24
| -71% | -$34.7K |
|
6149
CALL
Hooker Furnishings Corp
HOFT
$166M
| $7.48K | ﹤0.01% |
400
+300
| +300% | +$4.84K |
|
6150
CALL
Carter's
CRI
$1.47B
| $7.46K | ﹤0.01% |
+100
| New | +$7.17K |
|
Similar funds
SCP
Group One Trading's Q4 2022 Portfolio in Review
As of Q4 2022, Group One Trading held 8,577 positions worth $43B, down 16% from $50.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Group One Trading withdrew a net $3.97B in Q4 2022, closing 1,444 positions and reducing 3,270 holdings. Its most notable exit was Biogen, an estimated $30.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.4% of assets, down from 1.5% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Group One Trading opened a new position in Cigna worth $165M.
- Group One Trading's largest Q4 2022 buy was Cigna: 497,989 shares worth $165M.
- Group One Trading added most to Microsoft in Q4 2022, an estimated $62.9M increase.
- Group One Trading's biggest Q4 2022 reduction was Tesla, cutting an estimated $128M.
- Group One Trading fully exited Biogen in Q4 2022, selling an estimated $30.6M.
- Group One Trading's ten largest holdings make up 22% of its $43B portfolio in Q4 2022.
- Group One Trading opened 1,058 new positions and closed 1,444 in Q4 2022.
- Group One Trading's portfolio value fell 16% quarter-over-quarter to $43B.
Based on Group One Trading's 13F filing for Q4 2022, filed 9 Feb 2023.